Group Sues FDA Over Drug Linked To Liver Damage

A U.S. consumer group on Monday sued the Food and Drug Administration in an effort to force a ban on a Bristol-Myers Squibb antidepressant linked to life-threatening liver damage. The group, Public Citizen, said it filed the suit because the FDA had failed to act on a petition filed more than a year ago to outlaw the drug, called Serzone. Serzone has been pulled from the market in Europe and Canada and is slated to be withdrawn in Australia and New Zealand in May, Public Citizen said.